Indefinite Delivery Contract SPE2DB22D2206

This indefinite delivery contract was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation as a single award IDV to provide pharmaceutical products and medical supplies. The prime vendor is to deliver items from its corporate office in Conshohocken, Pennsylvania to support DLA's global supply chain operations. Task orders issued against the vehicle between October 2023 and December 2025 procure a range of prescription drugs, medical devices, and consumable supplies for approximately $1 billion to fulfill the Agency's mandate of logistics support to the Department of Defense. Notable orders supply branded and generic medications to treat conditions like pulmonary fibrosis, cytomegalovirus, and idiopathic pulmonary fibrosis, as well as contrast media, saline solutions, wound dressings, and pancreatic enzymes. Performance periods are generally one week or less. No set-aside provisions or subcontracting arrangements are specified in the information provided.

The Defense Logistics Agency acts as the logistics combat support agency for the Department of Defense, responsible for worldwide logistics support functions. This IDV and associated task orders allow DLA to leverage an existing contractor's distribution infrastructure to efficiently provision pharmaceuticals and medical commodities for its military treatment facility customers and partners. Timely access to these medical supplies helps ensure military readiness and supports the delivery of healthcare both during deployment and stateside.